FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

insulin news from FierceBioResearcher

News

Buck Institute to tackle aging research with stem cell funds

The Buck Institute for Age Research was the only non-academic group to receive California stem cell grants for new research facilities this year. After qualifying for $20.5 million in state funds, Read more...

Developers, geneticists brainstorm diabetes therapies

What do you get when you mix 20 drug developers active in the diabetes field with a room full of geneticists? Hopefully, a new generation of therapies that pinpoint subsets of the disease, each with Read more...

Press Release: Reducing Insulin Signaling in the Brain Can Prolong Lifespan

One route to a long and healthy life may be establishing the right balance in insulin signaling between the brain and the rest of the body, according to new research from Children’s Hospital Read more...

ALSO NOTED: Stem cells produce insulin; Breakthrough in breast cancer genomics;

Stem Cell Research

Using stem cells extracted from umbilical cords, researchers at the University of Texas Medical Branch teamed with scientists in the UK were able to coax them to produce insulin, offering an approach to curing diabetes. Dr. Randall Urban, who led the study, said that they were on the first rung of the ladder. The news follows a report from last week that Geron had used embryonic stem cells to create new …

Read more...

Geron reports breakthrough in stem cell research

Geron stock got a big boost just days ago when researchers announced that they had coaxed embryonic stem cells into clusters that produced insulin in response to elevated levels of glucose. The work points to a potential cure for Type 1 diabetes, which had investors cheering up its stock by about 10 percent. Some analysts note that the company has been the subject of a considerable amount of press attention, which hasn't hurt its stock price.

"These studies show that the islet-like …

Read more...

ALSO NOTED: Geron touts clinical trials; Wisconsin start-up gets state funds; new artificial blood developed

Stem cell research

Geron CEO Tom Okarma used BIO 2007 as a setting to tout upcoming clinical trials of an embryonic stem cell therapy for spinal cord injuries. "The world's spotlight will be on this trial," he maintains, which some observers see as a possible blessing or a curse. Report

UC Irvine neurobiologist Hans Keirstead and his research team have launched a …

Read more...
Tags: Stem Cells   pancreas   insulin   Geron  

ALSO NOTED: New type of cells developed for tissue repair; diabetes drug boosts efficacy of cancer drug;

Stem Cell Research

Advanced Cell Technology has turned embryonic stem cells into repair cells that can be used to repair tissue damage. Depending on the chemical used to spur change in the cell, the stem cells can be transformed to hemangioblasts that can be used as blood-building cells or cells that form the lining of blood vessels. Report

Scientists have …

Read more...

Genetically modified cows to produce cheap insulin

Scientists working for Bio Sidus in Argentina have developed a genetically modified cow that can produce insulin in its milk. The company says the four cloned calves will start producing the insulin-rich milk when they reach maturity. To clone the cows, scientists insert a human gene into an embryo, which is then implanted in the mother. The insulin is later extracted from the milk. Bio Sidus said that the procedure can be used to develop insulin for 30 percent less than current methods …

Read more...
Tags: embryo   Diabetes   insulin   cloning  

Researcher touts new work on insulin-producing cells

Wendy Macfarlane of Britain's Brighton University told an international diabetes conference in South Africa that new work in the field indicates that efforts to make both embryonic and adult stem cells produce insulin can lead to animal studies of a replacement beta cell by the turn of the decade. The goal is to develop an insulin producing cell that can respond to the fluctuation of glucose levels in the body. Diabetes kills 3.8 million people every year and has been …

Read more...
Tags: genetics   Stem Cells   insulin  

Scientists grow new heart valves from stem cells

Scientists at the University of Zurich have used stem cells obtained from fetal fluid to grow new heart valves for repairing damaged hearts. The work builds on new research into growing bladders and blood vessels from stem cells as researchers find more effective ways to mend or replace damaged body parts. By using stem cells drawn from the patient, researchers say they will eventually be able to provide new body parts that will be far superior to transplants. These parts will be able to …

Read more...

Get more insulin coverage at: